Induced pluripotent stem cells: Progress towards a biomedical application

Expert Review of Cardiovascular Therapy

Volumn 9, Issue 10, 2011, Pages 1265-1269

  Barile, Lucio ^a   Altomare, Claudia ^a   Zaza, Antonio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Cardiac differentiation; Cardiovascular disease; Induced pluripotent stem cell

Indexed keywords

ARTICLE; CELL AGGREGATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL GROWTH; CELL SPECIFICITY; EMBRYO; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MEDICAL TECHNOLOGY; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL;

EID: 80053973642     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.11.123     Document Type: Article

References (29)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663-676 (2006). (Pubitemid 44233629)
2. Carey BW, Markoulaki S, Hanna J et al. Reprogramming of murine and human somatic cells using a single polycistronic vector. Proc. Natl Acad. Sci. USA 106, 157-162 (2009).
3. Oda Y, Yoshimura Y, Ohnishi H et al. Induction of pluripotent stem cells from human third molar mesenchymal stromal cells. J. Biol. Chem. 285, 29270-29278 (2010).
4. Nakagawa M, Koyanagi M, Tanabe K et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotechnol. 26, 101-106 (2008).
5. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, Woltjen K. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458, 771-775 (2009).
6. Okita K, Nakagawa M, Hyenjong H, Ichisaka T, Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science (New York) 322, 949-953 (2008).
7. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR. Transcriptional signature and memory retention of human-induced pluripotent stem cells. PloS One 4, e7076 (2009).
8. Mitcheson JS, Hancox JC, Levi AJ. Cultured adult cardiac myocytes: future applications, culture methods, morphological and electrophysiological properties. Cardiovasc. Res. 39, 280-300 (1998). (Pubitemid 28346525)
9. Itzhaki I, Maizels L, Huber I et al. Modelling the long QT syndrome with induced pluripotent stem cells. Nature 471, 225-229 (2010).
10. Moretti A, Bellin M, Welling A et al. Patient-specific induced pluripotent stem-cell models for long-QT syndrome. N. Engl. J. Med. 363, 1397-1409 (2010).
11. Burridge PW, Thompson S, Millrod MA et al. A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability. PloS One 6, e18293 (2011).
12. Bouchard F, Paquin J. Skeletal and cardiac myogenesis accompany adipogenesis in P19 embryonal stem cells. Stem Cell Dev. 18, 1023-1032 (2009).
13. Gai H, Leung EL, Costantino PD et al. Generation and characterization of functional cardiomyocytes using induced pluripotent stem cells derived from human fibroblasts. Cell Biol. Int. 33, 1184-1193 (2009).
14. Smits AM, Van Laake LW, Den Ouden K et al. Human cardiomyocyte progenitor cell transplantation preserves long-term function of the infarcted mouse myocardium. Cardiovasc. Res. 83, 527-535 (2009).
15. So KH, Han YJ, Park HY et al. Generation of functional cardiomyocytes from mouse induced pluripotent stem cells. Int. J. Cardiol. DOI: 10.1016/j.ijcard.2010.08.052 (2011) (Epub ahead of print).
16. Warren L, Manos PD, Ahfeldt T et al. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell 7, 618-630 (2011).
17. Yu J, Hu K, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science (New York) 324, 797-801 (2009).
18. Meissner A, Wernig M, Jaenisch R. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells. Nat. Biotechnol. 25, 1177-1181 (2007). (Pubitemid 47538112)
19. Wernig M, Zhao JP, Pruszak J et al. Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proc. Natl Acad. Sci. USA 105, 5856-5861 (2008). (Pubitemid 351758462)
20. Bondue A, Tannler S, Chiapparo G et al. Defining the earliest step of cardiovascular progenitor specification during embryonic stem cell differentiation. J. Cell Biol. 192, 751-765 (2011).
21. Kapur N, Banach K. Inositol-1,4,5- trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes. J. Physiol. 581, 1113-1127 (2007). (Pubitemid 46887982)
22. 2+ handling in mouse ventricular cells from early embryo to adulthood. Life Sci. 71, 1279-1292 (2002). (Pubitemid 34775207)
23. Itzhaki I, Rapoport S, Huber I et al. Calcium handling in human induced pluripotent stem cell derived cardiomyocytes. PloS One 6, e18037 (2011).
24. 2+ signaling as an index of cardiac progenitor cells differentiation. Basic Res. Cardiol. 105, 737-749 (2011).
25. Okita K, Ichisaka T, Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 448, 313-317 (2007). (Pubitemid 47080336)
26. Stadtfeld M, Nagaya M, Utikal J, Weir G, Hochedlinger K. Induced pluripotent stem cells generated without viral integration. Science (New York) 322, 945-949 (2008).
27. Ichida JK, Blanchard J, Lam K et al. A small-molecule inhibitor of TGF-b signaling replaces SOX2 in reprogramming by inducing Nanog. Cell Stem Cell 5, 491-503 (2009).
28. Aoi T, Yae K, Nakagawa M et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science (New York) 321, 699-702 (2008).
29. Kim JB, Greber B, Arauzo-Bravo MJ et al. Direct reprogramming of human neural stem cells by OCT4. Nature 461, 649-643 (2009).